Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 138.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.50 (1.818%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 138.50
XAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

29 Nov 2023 07:00

RNS Number : 9778U
Xaar PLC
29 November 2023
 

29 November 2023

 

XAAR plc 

 

TRADING UPDATE

 

Xaar plc ("Xaar", "the Group" or "the Company"), the leading inkjet printing technology group, today provides a trading update.

 

PROFIT AHEAD OF EXPECTATIONS FOR 2023

· Through disciplined cost management, a favourable product mix and new customer product launches the Group is expected to deliver an adjusted profit before tax of between £2.5 million and £3 million, which is ahead of Board expectations.

 

· Trading conditions have become more challenging in H2 2023 due to the wider economic environment. As a result, 2023 full year revenues are expected to be between £70 million and £72 million.

 

2024 OUTLOOK

 

· The Board anticipates that weaker demand during Q4 2023 will continue into 2024, and together with delays in some customer product launches, will result in lower revenue and adjusted profit in 2024 than previously anticipated. We are optimistic and remain focused on delivering significant opportunities in our customer pipeline.

 

· In 2024 the Group also faces the full effect of increased input costs. The lower than previously expected revenue growth in 2024 will not be sufficient to fully absorb the additional costs, which will impact Gross Margin.

 

· The Group continues to implement initiatives designed to improve operating efficiencies throughout the organisation and to reduce operating costs, whilst continuing to deliver on our strategic plan.

 

· The Board remains confident in the medium-term outlook as our opportunities continue to strengthen and further product launches are expected in 2024. This provides confidence in delivering our mid-term growth plans, whilst ensuring a balance between targeted investment and expected returns in the short term.

 

BALANCE SHEET

 

The Group remains well capitalised with a strong balance sheet and with a net cash position of £3.7 million as at 28 November 2023 which is in line with management expectations. The Group also has an undrawn revolving credit facility of £5m.

 

John Mills, Chief Executive Officer, commented:

"Whilst the external trading environment is challenging, we remain focused on the delivery of our strategy and taking advantage of the significant opportunities we have that will drive profitable growth. Our products continue to generate strong interest from customers, demonstrating our leadership in printing highly viscous fluids with all the performance and sustainability benefits they deliver.

"Due to the current geo-political and macro conditions, bringing these products to market is taking longer than expected, however, we are optimistic about the future, and we are well placed to benefit as trading conditions improve."

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

 

Enquiries:

 

Xaar plc

+44 (0) 1223 423 663 

Ian Tichias, Chief Financial Officer

John Mills, Chief Executive Officer

 

Teneo Communications

Giles Kernick

Olivia Lucas

+44 (0) 207 353 4200

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTNKFBBDBDBNDB
Date   Source Headline
11th Jun 20124:31 pmRNSDirector/PDMR Shareholding
7th Jun 201210:10 amRNSHolding(s) in Company
1st Jun 20129:24 amRNSDirector Declaration
31st May 20124:54 pmRNSTotal Voting Rights
22nd May 20124:54 pmRNSResult of AGM
17th May 20121:21 pmRNSHolding(s) in Company
4th May 20127:00 amRNSNotice of AGM
3rd May 20124:35 pmRNSHolding(s) in Company
2nd May 20123:12 pmRNSGrant of Options
1st May 20129:38 amRNSTotal Voting Rights
25th Apr 20125:21 pmRNSHolding(s) in Company
25th Apr 201211:26 amRNSDirector/ PDMR Shareholding
23rd Apr 20127:00 amRNSDirector/PDMR Shareholding
19th Apr 20127:00 amRNSAnnual Information Update
19th Apr 20127:00 amRNSInterim Management Statement
16th Apr 20126:13 pmRNSDirector/PDMR Shareholding - Replacement
13th Apr 20128:54 amRNSDirector/PDMR Shareholding
5th Apr 20123:25 pmRNSDirector/PDMR Shareholding
3rd Apr 20127:00 amRNSIssue of Options
30th Mar 20125:39 pmRNSTotal Voting Rights
19th Mar 20127:00 amRNSFinal Results
15th Mar 20127:00 amRNSHolding(s) in Company
9th Mar 20124:00 pmRNSHolding(s) in Company
1st Mar 20128:30 amRNSHolding(s) in Company
29th Feb 20128:48 amRNSHolding(s) in Company
28th Feb 20127:00 amRNSChange of 2011 Results Announcement Date
20th Feb 20125:33 pmRNSHolding(s) in Company
20th Feb 20125:24 pmRNSHolding(s) in Company
24th Jan 20126:05 pmRNSHolding(s) in Company
24th Jan 20127:00 amRNSChina Staff Changes
19th Jan 20127:00 amRNSTrading Statement
23rd Dec 20117:02 amRNSTotal Voting Rights
23rd Dec 20117:01 amRNSBlocklisting Interim Review
23rd Dec 20117:00 amRNSIssue of Options
24th Nov 20119:58 amRNSHolding(s) in Company
18th Nov 20113:23 pmRNSBlocklisting Interim Review
17th Nov 20115:31 pmRNSHolding(s) in Company
21st Oct 201112:06 pmRNSHolding(s) in Company
20th Oct 20117:00 amRNSInterim Management Statement
11th Oct 201112:24 pmRNSHolding(s) in Company
4th Oct 201112:59 pmRNSTotal Voting Rights
30th Sep 20119:04 amRNSDirector/PDMR Shareholding
26th Sep 20115:50 pmRNSHolding(s) in Company
26th Aug 20115:21 pmRNSHolding(s) in Company
23rd Aug 20114:14 pmRNSDirector/PDMR Shareholding
18th Aug 20111:55 pmRNSHalf Yearly Report - Replacement
18th Aug 20117:00 amRNSInterim Management Statement
5th Aug 20112:59 pmRNSAdditional Listing
7th Jul 20117:00 amRNSInterim Trading Update
21st Jun 20114:34 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.